H.R. 7406House118th Congress (2023-2025)Passed House

DeOndra Dixon INCLUDE Project Act of 2024

Introduced February 16, 2024

AI-Generated Summary

Updated January 20, 2026 at 2:47 PM UTC

The DeOndra Dixon INCLUDE Project Act amends the Public Health Service Act to create a new NIH‑led program called the INCLUDE Project, focused on research, training, and investigation of Down syndrome and its co‑occurring conditions. It directs the Secretary of Health and Human Services to coordinate and expand studies, clinical trials, and biomarker development to improve health outcomes and quality of life for individuals with Down syndrome and their families. The bill also requires biennial reporting to Congress and authorizes $90 million annually from FY2025 through FY2029 to fund the effort.

Key Provisions

  • Establishes the INCLUDE Project to conduct Down syndrome research, training, and investigation through NIH and partner agencies.
  • Specifies program elements including basic science on chromosome 21, building a large study cohort, expanding inclusive clinical trials, studying biological mechanisms, identifying biomarkers, and addressing co‑occurring conditions such as Alzheimer’s disease.
  • Mandates coordination among NIH institutes and other federal entities to avoid duplicate research and prioritize non‑duplicative studies.
  • Provides technical assistance to grantees and other participants in the program.
  • Requires the Secretary to submit biennial reports to relevant congressional committees detailing research activities, participating entities, and real‑world evidence generated.
  • Authorizes $90 million in appropriations each fiscal year from 2025 to 2029, to supplement—not replace—existing NIH funding for Down syndrome research.

Legislative Activity

Stay on top of the latest movement without scrolling through every action

15 earlier actions
SenateIntro Referral Latest Action

Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

September 18, 2024

View full timeline
HouseIntro Referral

Introduced in House

February 16, 2024

HouseIntro Referral

Referred to the House Committee on Energy and Commerce.

February 16, 2024

HouseCommittee

Referred to the Subcommittee on Health.

February 23, 2024

HouseCommittee

Subcommittee Consideration and Mark-up Session Held

March 12, 2024

HouseCommittee

Forwarded by Subcommittee to Full Committee (Amended) by Voice Vote.

March 12, 2024

HouseCommittee

Committee Consideration and Mark-up Session Held

March 20, 2024

HouseCommittee

Ordered to be Reported (Amended) by the Yeas and Nays: 45 - 0.

March 20, 2024

HouseCommittee

Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 118-504.

May 14, 2024

HouseCalendars

Placed on the Union Calendar, Calendar No. 419.

May 14, 2024

HouseFloor

Mrs. Rodgers (WA) moved to suspend the rules and pass the bill, as amended.

September 17, 2024 • 8:45 PM

HouseFloor

Considered under suspension of the rules. (consideration: CR H5304-5306)

September 17, 2024 • 8:45 PM

HouseFloor

DEBATE - The House proceeded with forty minutes of debate on H.R. 7406.

September 17, 2024 • 8:45 PM

HouseFloor

Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H5304-5305)

September 17, 2024 • 8:54 PM

HouseFloor

On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H5304-5305)

September 17, 2024 • 8:54 PM

HouseFloor

Motion to reconsider laid on the table Agreed to without objection.

September 17, 2024 • 8:54 PM

SenateIntro Referral

Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

September 18, 2024

Floor Debate

3 members

What members said about H.R. 7406 on the floor

2 Republicans1 Democrat
Pete Stauber
Rep. Pete StauberR-MN-8 · Sep 17, 2024

Mr. Speaker, I thank Chairwoman Rodgers for her support and steadfast leadership on this issue. Mr. Speaker, I rise today to speak not just as a Member of Congress but as a father to a 22-year-old…

Cathy McMorris Rodgers
Rep. Cathy McMorris RodgersR-WA-5 · Sep 17, 2024

Mr. Speaker, I move to suspend the rules and pass the bill (H.R. 7406) to amend the Public Health Service Act to authorize the Secretary of Health and Human Services to carry out a program of…

Frank Pallone, Jr.
Rep. Frank Pallone, Jr.D-NJ-6 · Sep 17, 2024

Mr. Speaker, I yield myself such time as I may consume. Mr. Speaker, I rise to speak in support of H.R. 7406, the DeOndra Dixon INCLUDE Project Act, sponsored by Chair Rodgers and Representatives…

Bill Text

4 versions available

Reading Mode
Latest
Referred in SenateIssued September 18, 2024

IIB

118th CONGRESS

2d Session

H. R. 7406

IN THE SENATE OF THE UNITED STATES

September 18, 2024

Received; read twice and referred to the Committee on Health, Education, Labor, and Pensions

AN ACT

To amend the Public Health Service Act to authorize the Secretary of Health and Human Services to carry out a program of research, training, and investigation related to Down syndrome, and for other purposes.


1.

Short title

This Act may be cited as the DeOndra Dixon INCLUDE Project Act of 2024.

2.

Down syndrome research

Part A of title IV of the Public Health Service Act (42 U.S.C. 281 et seq.) is amended by adding at the end the following:

404P.

Down syndrome research

(a)

In general

The Secretary, acting through the Office of the Director of NIH, and in consultation with other Federal agencies and partners, shall carry out a program of research, training, and investigation related to Down syndrome to be known as the INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE Project or the INCLUDE Project.

(b)

Program elements

The program under subsection (a) shall include research, training, and investigation related to—

(1)

high-risk, high reward basic science studies of the effects of chromosome 21 on human development and health;

(2)

assembling and maintaining a large study population of individuals with Down syndrome;

(3)

expanding the number of clinical trials that are inclusive of, or expressly for, individuals with Down syndrome, including novel biomedical and pharmacological interventions and other therapies designed to promote or enhance activities of daily living;

(4)

the biological mechanisms in individuals with Down syndrome responsible for structural and functional anomalies in cells, tissues, and organs, cognitive and behavioral dysfunction, and stunted growth;

(5)

the identification of biomarkers for the detection of risk factors, diagnosis, and customized interventions and treatments for conditions co-occurring with Down syndrome;

(6)

why several co-occurring conditions, such as Alzheimer’s Disease and autoimmunity, are prevalent in individuals with Down syndrome and how such conditions can be treated concurrently with Down syndrome; and

(7)

improving the quality of life of individuals with Down syndrome and their families.

(c)

Coordination; prioritizing nonduplicative research

The Secretary shall ensure that—

(1)

the programs and activities of the institutes, centers, agencies, and offices of the National Institutes of Health relating to Down Syndrome and co-occurring conditions are coordinated, including through the Division of Program Coordination, Planning, and Strategic Initiatives under sections 402(b)(7) and 402A(c); and

(2)

such institutes, centers, agencies, and offices prioritize, as appropriate, Down syndrome research that does not duplicate existing research activities of the National Institutes of Health.

(d)

Technical assistance

The Secretary shall provide technical assistance to grantees and other involved entities, as appropriate, for carrying out activities pursuant to this section.

(e)

Biennial reports to congress

(1)

In general

The Secretary shall submit, on a biennial basis, to the Committee on Energy and Commerce and the Subcommittee on Labor, Health and Human Services, Education of the Committee on Appropriations of the House of Representatives and the Committee on Health, Education, Labor, and Pensions and the Subcommittee on Labor, Health and Human Services, Education, and Related Agencies of the Committee on Appropriations of the Senate, a report that catalogs the research conducted or supported under this section.

(2)

Contents

Each report under paragraph (1) shall include—

(A)

identification of the institute, center, agency, office, or entity involved;

(B)

a statement of whether the research is or was being carried out directly by the institute, center, agency, office, or entity or by multiple institutes, centers, agencies, offices, or entities; and

(C)

identification of any resulting real world evidence that is or may be used for clinical research and medical care for patients with Down syndrome.

(f)

Authorization of appropriations

(1)

In general

To carry out this section, there is authorized to be appropriated $90,000,000 for each of fiscal years 2025 through 2029.

(2)

Supplement, not supplant

Funds appropriated to carry out this section shall be used to supplement, not supplant, other funds allocated by the National Institutes of Health for research and other activities relating to Down syndrome.

.

Passed the House of Representatives September 17, 2024.

Kevin F. McCumber,

Clerk.